Orser Capital Management, LLC Merck & Co., Inc. Transaction History

Orser Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$123.8 - $132.96 $8,666 - $9,307	-70 Reduced 3.89%	1,729 $214,000
Q1 2024 Apr 11, 2024	SELL	$113.24 - $131.95 $23,780 - $27,709	-210 Reduced 10.45%	1,799 $237,000
Q4 2023 Jan 09, 2024	SELL	$100.18 - $109.02 $715,786 - $778,947	-7,145 Reduced 78.05%	2,009 $219,000
Q3 2023 Oct 10, 2023	SELL	$102.95 - $114.33 $12,354 - $13,719	-120 Reduced 1.29%	9,154 $942,000
Q2 2023 Jul 11, 2023	SELL	$108.61 - $118.38 $3,801 - $4,143	-35 Reduced 0.38%	9,274 $1.07 Million
Q1 2023 Apr 11, 2023	BUY	$102.94 - $114.86 $958,268 - $1.07 Million	9,309 New	9,309 $990,000
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $873,282 - $1.03 Million	-12,682 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$71.77 - $79.65 $439,591 - $487,856	6,125 Added 93.41%	12,682 $1.04 Million
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $415,451 - $575,835	6,557 New	6,557 $504,000
Q1 2018 Nov 14, 2019	SELL	$50.96 - $59.23 $326,194 - $379,131	-6,401 Closed	0 $0
Q4 2017 Nov 19, 2019	BUY	$51.62 - $61.64 $330,419 - $394,557	6,401	6,401 $404,000

3,828

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Orser Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Orser Capital Management, LLC with notifications on news.